Chemotherapy-Induced Nausea and Vomiting. 2015

Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
The Medical Oncology Center of Rosebank, Saxonwold, Johannesburg 2196, South Africa.

UI MeSH Term Description Entries
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic
D014839 Vomiting The forcible expulsion of the contents of the STOMACH through the MOUTH. Emesis
D058831 Serotonin 5-HT3 Receptor Antagonists Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. 5-HT3 Antagonist,5-HT3 Antagonists,5 HT3 Antagonist,5 HT3 Antagonists,Antagonist, 5-HT3,Antagonists, 5-HT3,Serotonin 5 HT3 Receptor Antagonists
D018040 Receptors, Neurokinin-1 A class of cell surface receptors for TACHYKININS with a preference for SUBSTANCE P. Neurokinin-1 (NK-1) receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells. NK-1 Receptors,Neurokinin-1 Receptors,Receptors, Substance P,SP-P Receptors,Substance P Receptors,NK-1 Receptor,Neurokinin-1 Receptor,Receptors, NK-1,Receptors, SP-P,SP-P Receptor,Substance P Receptor,Substance-P Receptor,Tachykinin Receptor 1,NK 1 Receptor,NK 1 Receptors,Neurokinin 1 Receptor,Neurokinin 1 Receptors,P Receptor, Substance,P Receptors, Substance,Receptor, NK-1,Receptor, Neurokinin-1,Receptor, SP-P,Receptor, Substance P,Receptor, Substance-P,Receptors, NK 1,Receptors, Neurokinin 1,Receptors, SP P,SP P Receptor,SP P Receptors

Related Publications

Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
January 2008, US oncology,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
September 1979, The American journal of nursing,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
October 1993, Postgraduate medicine,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
January 2002, Clinical journal of oncology nursing,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
June 2008, The New England journal of medicine,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
January 2008, Cancer journal (Sudbury, Mass.),
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
April 1995, The American journal of nursing,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
October 1990, Current opinion in oncology,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
January 1994, Irish medical journal,
Bernardo Leon Rapoport, and Alexander Molasiotis, and Haralambos Raftopoulos, and Fausto Roila
April 2005, Clinical journal of oncology nursing,
Copied contents to your clipboard!